Description
Izoniazid Tablets 0.2 №50
Ingredients
Each tablet contains 0.2mg of Isoniazid.
Mechanism of Action
Isoniazid works by inhibiting the synthesis of mycolic acids in the cell wall of tuberculosis bacteria, leading to cell death.
Pharmacological Properties
Isoniazid disrupts the bacterial cell wall structure, ultimately killing the tuberculosis bacteria.
Indications for Use
Izoniazid tablets are primarily indicated for the treatment of tuberculosis by targeting and eliminating the bacteria responsible for the infection.
Contraindications
Avoid Izoniazid if you have a history of liver disease or if you are allergic to Isoniazid. Consult your healthcare provider before initiating treatment with this medication.
Side Effects
Common side effects of Izoniazid may include nausea, vomiting, and liver toxicity. Contact your doctor if you experience any unusual symptoms.
Usage Instructions
The typical adult dosage of Izoniazid is 300mg daily. Take the tablets on an empty stomach, either 1 hour before or 2 hours after meals. Swallow the tablets whole; do not crush or chew them.
Benefits Compared to Analogues
Izoniazid has shown proven effectiveness in treating tuberculosis, especially when used in combination with other anti-tuberculosis medications. Its mechanism of action targets the bacteria directly, aiding in successful treatment outcomes.
Suitable Patient Groups
Izoniazid is suitable for various patient groups, including adults, children, and the elderly, under appropriate medical supervision. Dosage adjustments may be necessary based on individual patient factors.
Storage and Shelf Life
Store Izoniazid tablets in a cool, dry place away from moisture and sunlight. Check the expiration date on the packaging and do not use expired medication.
Packaging Description
Izoniazid tablets are typically packaged in blister packs of 50 tablets each, ensuring convenient and accurate dosing for the prescribed treatment duration.
Scientific Evidence
Isoniazid has been extensively studied and proven effective in treating tuberculosis. Research published in reputable journals, such as the New England Journal of Medicine, demonstrates its ability to significantly reduce bacterial load in patients with active tuberculosis when used in combination therapy.
Clinical Evidence and Proven Effectiveness
Clinical studies have shown that Izoniazid, when administered as part of a comprehensive anti-tuberculosis regimen, leads to successful treatment outcomes and reduces the risk of developing drug-resistant strains of tuberculosis bacteria.
Additional Information
Completing the full course of Izoniazid treatment as prescribed is crucial to prevent the development of drug-resistant tuberculosis strains. Contact your healthcare provider if you encounter any unexpected symptoms during the course of treatment.
